Free T3 (Free Triiodothyronine) Test
The Free T3 test measures free triiodothyronine, the unbound and biologically active fraction of T3, in serum. It is primarily indicated for assessing the severity of hyperthyroidism, detecting T3 toxicosis, and characterising non-thyroidal illness syndrome. TSH and Free T4 remain the first-line markers for thyroid screening and hypothyroidism.
1
Biomarkers
Blood (serum)
Sample
1–3 business days
Turnaround
No — however, practitioners should document timing relative to any T3-containing thyroid medication, as recent dosing transiently elevates Free T3
Fasting
What is the Free T3 test?
The Free T3 Test measures Free Triiodothyronine — the unbound, biologically active fraction of T3 that drives metabolic activity at the tissue level. Because it is unaffected by changes in binding protein concentration, it provides a direct index of active thyroid hormone status and is most informative when thyroid overactivity is suspected. In routine thyroid assessment, TSH and Free T4 remain the first-line markers for screening and for hypothyroidism, where Free T3 adds little. Free T3 earns its place in the workup of hyperthyroidism — particularly to detect T3 toxicosis, in which Free T3 rises while Free T4 may remain within range — and in monitoring treatment response in established thyrotoxicosis. Practitioners also order it to interpret discordant thyroid panels and to characterise the low-T3 pattern of non-thyroidal illness.
What does the Free T3 test measure?
Triiodothyronine is the metabolically active thyroid hormone. Approximately 80% of circulating T3 derives from peripheral deiodination of T4 by type 1 and type 2 deiodinases, with the remaining ~20% secreted directly by the thyroid. Free T3 represents the unbound fraction — roughly 0.3% of total T3 — that is available to bind nuclear thyroid hormone receptors. The bound majority is carried by TBG, transthyretin, and albumin. Free T3 has a short circulating half-life of approximately one day.
Free T3 reflects the bioavailable, receptor-active thyroid hormone pool, making it the marker of choice when assessing the severity of thyrotoxicosis and identifying T3-predominant hyperthyroidism (T3 toxicosis). It also assists in characterising non-thyroidal illness syndrome, where peripheral T4-to-T3 conversion falls. Free T3 has limited utility in primary hypothyroidism diagnosis, where TSH and Free T4 remain the first-line markers.
Why is the Free T3 test ordered?
- Investigation of suspected hyperthyroidism where TSH is suppressed — Free T3 confirms the degree of hormone excess and identifies T3-predominant disease
- Detection of T3 toxicosis — patients with suppressed TSH and normal Free T4 in whom isolated Free T3 elevation is the only biochemical marker
- Monitoring response to antithyroid therapy in Graves' disease or toxic nodular goitre, where Free T3 normalisation lags behind Free T4
- Evaluation of discordant thyroid panels — suppressed TSH with equivocal Free T4 requiring Free T3 to clarify thyroid status
- Assessment of non-thyroidal illness syndrome in acutely or chronically ill patients, where reduced peripheral T4-to-T3 conversion produces a low-T3 pattern
- Characterisation of suspected impaired deiodinase activity or peripheral conversion concerns in functional and integrative thyroid assessment
- Follow-up of patients on combination T4/T3 or liothyronine therapy where the active hormone fraction is being titrated
Sample collection and turnaround
Sample type
Blood (serum)
Fasting required
No — however, practitioners should document timing relative to any T3-containing thyroid medication, as recent dosing transiently elevates Free T3
Collection method
Venipuncture at patient service centre
Turnaround
1–3 business days
Collection notes
No special preparation required beyond noting thyroid medication timing. Advise patients to withhold high-dose biotin supplementation for 48–72 hours prior to collection to avoid immunoassay interference.
Specimen requirements
Minimum 0.5 mL serum. Separate serum from cells within 2 hours of collection. Specimen stable refrigerated; follow Access Medical Laboratories transport protocol.
What can affect Free T3 results?
Systemic illness downregulates type 1 deiodinase and shifts T4 metabolism toward reverse T3, lowering Free T3 independent of intrinsic thyroid function. This is the low-T3 pattern of euthyroid sick syndrome.
Exogenous T3 raises Free T3 directly, often with transient peaks following dosing. Specimen timing relative to the last dose materially affects the result and should be documented.
Biotin can interfere with streptavidin-biotin immunoassay platforms, producing falsely elevated or reduced Free T3 depending on assay architecture. Patients should withhold biotin for 48–72 hours before collection.
Propranolol and some other beta-blockers inhibit peripheral T4-to-T3 conversion at higher doses, modestly lowering Free T3 without reflecting a change in thyroidal output.
Pharmacological glucocorticoid doses suppress deiodinase-mediated conversion of T4 to T3 and can blunt TSH, reducing Free T3 levels.
Amiodarone inhibits deiodinase activity and carries a high iodine load, producing complex and variable effects on Free T3 that depend on duration of therapy and underlying thyroid status.
What do Free T3 results mean?
Elevated
Elevated Free T3 with suppressed TSH indicates hyperthyroidism — Graves' disease, toxic multinodular goitre, or toxic adenoma. Isolated Free T3 elevation with normal Free T4 and suppressed TSH defines T3 toxicosis. Recent liothyronine intake should be excluded.
Normal
A Free T3 within the reference range is concordant with euthyroid status when TSH and Free T4 are also normal. A normal Free T3 does not exclude early hypothyroidism, since Free T3 is preserved until late in the disease course.
Reduced
Reduced Free T3 with otherwise normal thyroid markers most often reflects non-thyroidal illness (low-T3 syndrome) rather than primary thyroid disease. In overt hypothyroidism Free T3 may fall, but it is a late and insensitive marker; TSH and Free T4 are preferred.
Note: Free T3 should not be used as a standalone or first-line screening marker. It is most reliable in the assessment of hyperthyroidism and adds little in suspected hypothyroidism. Results require interpretation alongside TSH and Free T4, and timing relative to any T3-containing therapy must be documented.
Frequently asked questions
Free T4 is the first-line marker for thyroid screening and hypothyroidism, while Free T3 measures the unbound, biologically active T3 fraction. Free T3 is most useful for grading hyperthyroidism and detecting T3 toxicosis, where it may be elevated even when Free T4 is normal.
How to access the Free T3 test
The Free T3 reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.
Create Free AccountAbout this page
Published: June 2, 2026
Last reviewed: June 2, 2026
- Ross DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. (2016)
- Jonklaas J, et al. Guidelines for the Treatment of Hypothyroidism. Thyroid. (2014)
- Sheehan MT. Biochemical Testing of the Thyroid: TSH is the Best and, Oftentimes, Only Test Needed. Clin Med Res. (2016)
- Garber JR, et al. Clinical practice guidelines for hypothyroidism in adults. Thyroid. (2012)
This content is for licensed healthcare practitioners only and does not constitute medical advice. Clinical decisions should be based on the full clinical picture and not on any single test result.
Related tests
thyroid endocrine
Free T4
The Free T4 test measures free thyroxine, the unbound and metabolically available fraction of T4, in serum. Interpreted alongside TSH, it confirms and localises thyroid dysfunction — diagnosing primary and central hypothyroidism, grading hyperthyroidism, and monitoring levothyroxine therapy. Free T4 has replaced Total T4 in routine practice because it is unaffected by binding-protein changes.
thyroid endocrine
TSH
The TSH test measures Thyroid Stimulating Hormone produced by the anterior pituitary gland. It is the recommended first-line screening test for thyroid dysfunction, with elevated TSH indicating primary hypothyroidism and suppressed TSH indicating hyperthyroidism. TSH alone does not assess T4-to-T3 conversion or exclude central hypothyroidism.
thyroid endocrine
Complete Thyroid Panel
The Complete Thyroid Panel measures six biomarkers — TSH, Free T3, Free T4, Reverse T3, TPO Antibodies, and TG Antibodies — providing the most comprehensive single-draw assessment of thyroid function, hormone conversion adequacy, and autoimmune thyroid disease status available to practitioners.